HomeStock ScreenerKerala AyurvedaFinancial Statements

Kerala Ayurveda Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Kerala Ayurveda (KERALAYUR) reported revenue ₹37 Cr, net profit ₹-7 Cr and EPS ₹-5.83, with a net profit margin of -18.9% and ROE of -63.6%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore Kerala Ayurveda intrinsic price to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -18.92% 2026 data
EBITDA Margin -13.51% 2026 data
Operating Margin -20.00% 2026 data
Return on Assets -5.07% 2026 data
Return on Equity -63.64% 2026 data

Balance Sheet Ratios

Current Ratio 1.96 2026 data
Equity Ratio 7.97% 2026 data
Asset Turnover 0.27 2026 data

KERALAYUR Revenue, Net Profit & EBITDA — Year-on-Year Growth

KERALAYUR YoY (Mar 2025 vs Mar 2026) — revenue +15.6%, net profit +53.3%, EBITDA +44.4%. For live price, earnings ratios and company overview, see Kerala Ayurveda screener.

Revenue Growth
+15.6%
Year-over-Year
Net Profit Growth
+53.3%
Year-over-Year
EBITDA Growth
+44.4%
Year-over-Year
Assets Growth
+7.0%
Year-over-Year
Equity Growth
-15.4%
Year-over-Year
Operating Cash Flow Growth
+600.0%
Year-over-Year
Financing Cash Flow Growth
-150.0%
Year-over-Year

KERALAYUR Income Statement — Revenue, EBITDA & Net Profit

Kerala Ayurveda revenue ₹37 Cr, EBITDA ₹-5 Cr, net profit ₹-7 Cr, EPS ₹-5.83 (2026) — net profit margin -18.9%. Review KERALAYUR earnings valuation to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Jun 2018 Dec 2018
Revenue 37 37 32 38 34 31 32 28 31 26 24 24 27 24 21 19 26 20 17 17 20 15 19 11 17 19 16 16 19 14 14 16
Expenses 42 40 42 33 35 25 27 27 32 25 23 22 25 22 19 18 25 18 18 15 15 14 18 10 14 16 15 15 17 13 13 14
EBITDA -5 -3 -9 5 0 6 5 1 -1 1 1 2 1 3 2 1 1 2 -1 2 5 0 1 1 3 3 2 2 2 1 1 2
Operating Profit Margin % -20.00% -14.00% -32.00% -15.00% -5.00% 18.00% 15.00% 3.00% -4.00% 2.00% 3.00% 6.00% 4.00% 9.00% 10.00% 3.00% -7.00% 3.00% -7.00% 12.00% 23.00% 1.00% 4.00% 6.00% 14.00% 13.00% 3.00% 11.00% 11.00% 10.00% 8.00% 13.00%
Depreciation 2 1 2 2 1 2 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 1 3 3 1 3 1 3 1 0 1 1 2 1 1 2 1 1 2 2 2 2 2 1 1 2 0 1 0 0 1 1 0
Profit Before Tax -8 -7 -14 3 -4 4 0 0 -2 0 -1 0 0 1 0 -1 0 -1 -4 0 3 -2 0 -1 1 2 1 1 2 0 1 2
Tax -1 -1 2 1 0 0 0 0 1 0 -1 0 1 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0
Net Profit -7 -6 -15 2 -5 4 1 1 -3 0 1 0 -1 1 0 -1 -1 -1 -4 0 3 -2 -1 0 1 2 0 1 2 0 0 2
Earnings Per Share (₹) -5.83 -7.23 -12.78 1.92 -3.81 3.10 0.50 0.33 -2.40 0.07 0.24 -3.24 -0.84 0.98 0.06 -0.77 -0.91 -1.19 -3.24 1.11 2.56 -1.00 -0.77 -0.26 0.90 1.43 -0.02 1.15 1.04 0.11 0.06 1.03

KERALAYUR Balance Sheet — Assets, Liabilities & Shareholders' Equity

KERALAYUR total assets ₹138 Cr, total equity ₹11 Cr, total liabilities ₹ Cr (2026) — ROE -63.6%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 138 129 133 115 110 115 103 92 103 81 73 73
Current Assets 47 41 56 34 37 44 33 28 42 22 14 14
Fixed Assets 49 47 41 46 44 33 33 33 33 34 34 33
Capital Work in Progress 8 9 7 7 5 14 14 12 11 6 0 0
Investments 15 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 73 85 61 62 68 56 47 59 41 39 40
LIABILITIES
Total Liabilities
Current Liabilities 24 28 28 55 42 67 63 59 48 24 54 55
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 11 13 21 8 8 5 10 5 10 9 -5 -8
Share Capital 13 12 12 11 11 11 11 11 11 11 11 11
Reserves & Surplus -2 -3 7 -5 -4 -7 -3 -7 -3 -4 -17 -20

KERALAYUR Cash Flow Statement — Operating, Investing & Financing

Kerala Ayurveda operating cash flow ₹5 Cr, investing ₹-15 Cr, financing ₹-10 Cr, net cash flow ₹-19 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 5 -1 10 -1 7 5 12 -10 4 6 0
Investing Activities -15 0 -7 -2 -1 -4 -3 -3 -3 -3 0
Financing Activities -10 20 -1 -13 6 1 -12 17 0 -2 2
Net Cash Flow -19 18 2 -16 12 2 -2 4 1 0 2